References
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (Updated 2020). Avaliable from: www.ginasthma.org.
- British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma: a National Clinical Guideline. London: BTS; 2016.
- Aagaard L, Hansen EH. Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials. Int J Clin Pharm. 2014;36(2):243–252. doi:https://doi.org/10.1007/s11096-014-9924-y.
- Gupta R, Fonacier LS. Adverse effects of nonsystemic steroids (inhaled, intranasal, and cutaneous): a review of the literature and suggested monitoring tool. Curr Allergy Asthma Rep. 2016;16(6):44. doi:https://doi.org/10.1007/s11882-016-0620-y.
- NICE guideline. Asthma: diagnosis, monitoring and chronic asthma management 2017. Avaliable from: www.nice.org.uk.
- Hon KL, Leung TF, Leung AK. Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses? Drug Des Devel Ther. 2014; 8:839–850. doi:https://doi.org/10.2147/DDDT.S39100.
- Ducharme FM, Noya FJ, Allen-Ramey FC, Maiese EM, Gingras J, Blais L. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors. Curr Med Res Opin. 2012;28(1):111–119. doi:https://doi.org/10.1185/03007995.2011.640668.
- Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF, Juniper EF, Ayres JG, Kemp L, Blyth A, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med. 2011;364(18):1695–1707. doi:https://doi.org/10.1056/NEJMoa1010846.
- Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi:https://doi.org/10.1016/j.jaci.2017.03.050.
- Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–1277. doi:https://doi.org/10.1016/j.jaci.2014.02.036.
- Erdem SB, Nacaroglu HT, Unsal Karkiner CS, Gunay I, Can D. Side effects of leukotriene receptor antagonists in asthmatic children. Iran J Pediatr. 2015;25(5):e3313 doi:https://doi.org/10.5812/ijp.3313.
- Erdem SB, Karaman S, Nacaroglu HT, Unsal Karkıner CS, Yazıcı S, Can D. Seizures as a rare but serious adverse effect of leukotriene receptor. Ann Allergy Asthma Immunol. 2016;117(1):99–101. doi:https://doi.org/10.1016/j.anai.2016.05.001.
- Benard B, Bastien V, Vinet B, Yang R, Krajinovic M, Ducharme FM. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Eur Respir J. 2017;50(2):1700148. doi:https://doi.org/10.1183/13993003.00148-2017.
- Haarman MG, van Hunsel F, de Vries TW. Adverse drug reactions of montelukast in children and adults. Pharmacol Res Perspect. 2017;5(5):e00341. doi:https://doi.org/10.1002/prp2.341.
- Aldea Perona A, García-Sáiz M, Sanz Álvarez E. Psychiatric disorders and montelukast in children: a disproportionality analysis of the VigiBase(®). Drug Saf. 2016; 39(1):69–78. doi:https://doi.org/10.1007/s40264-015-0360-2.
- Urdaneta E. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Eur Respir J. 2017;2250(5):1701984. doi:https://doi.org/10.1183/13993003.01984-2017.
- Taminskiene V, Vaitkaitiene E, Valiulis A, Turner S, Hadjipanayis A, Stukas R, Valiulis A. The self-reported quality of life of Lithuanian children with asthma was comparable to Western populations. Acta Paediatr. 2018;107(2):333–338. doi:https://doi.org/10.1111/apa.14140.
- Kalyva E, Eiser C, Papathanasiou A. Health-related quality of life of children with asthma: self and parental perceptions. Int J Behav Med. 2016;23(6):730–737. doi:https://doi.org/10.1007/s12529-016-9558-7.
- Product information singulair® (montelukast sodium) tablets and oral granules. https://secure.healthlinks.net.au/content/msd/pi.cfm. MK0476-AUS-2012-005115.
- Ravens-Sieberer U, Erhart M, Wille N, Wetzel R, Nickel J, Bullinger M. Generic health-related quality-of-life assessment in children and adolescents: methodological considerations. PharmacoEconomics. 2006;24(12):1199–1220. doi:https://doi.org/10.2165/00019053-200624120-00005.
- Eser E, Yüksel H, Baydur H, Erhart M, Saatli G, Ozyurt CB, Ozcan C, Ravens-Sieberer U. The psychometric properties of the new Turkish generic health-related quality of life questionnaire for children (Kid-KINDL). Turk Psikiyatri Derg. 2008;19(4):409–417.
- Wallerstedt SM, Brunlöf G, Sundström A, Eriksson AL. Montelukast and psychiatric disorders in children. Pharmacoepidem Drug Safe. 2009;18(9):858–864. doi:https://doi.org/10.1002/pds.1794.
- Hu Y, Cantarero-Arévalo L. Ethnic differences in adverse drug reactions to asthma medications: a systematic review. J Asthma. 2016;53(1):69–75. doi:https://doi.org/10.3109/02770903.2015.1058395.
- King C, McKenna A, Farzan N, Vijverberg SJ, van der Schee MP, Maitland-van der Zee AH, Arianto L, Bisgaard H, BØnnelykke K, Berce V, et al. Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation. Pharmacogenomics J. 2020;20(5):621–628. doi:https://doi.org/10.1038/s41397-019-0140-y.
- Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD. Association between leukotriene-modifying agents and suicide: what is the evidence? Drug Saf. 2011;34(7):533–544. doi:https://doi.org/10.2165/11587260-000000000-00000.
- Ding Q, Fang SH, Zhou Y, Zhang LH, Zhang WP, Chen Z, Wei EQ. Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice. Acta Pharmacol Sin. 2007;28(7):945–952. doi:https://doi.org/10.1111/j.1745-7254.2007.00576.x.
- Singh RK, Gupta S, Dastidar S, Ray A. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology. 2010;85(6):336–349. doi:https://doi.org/10.1159/000312669.
- Peters-Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med. 2007;357(18):1841–1854. doi:https://doi.org/10.1056/NEJMra071371.
- Reporting adverse drug reactions: definitions of terms and criteria for their use Geneva: Counsel for International Organizations of Medical Sciences (CIOMS); 1999. http://www.cioms.ch/publications/reporting_adverse_drug.pdf. Accessed 19 Sept 2018.
- Holmbeck GN, Li ST, Schurman JV, Friedman D, Coakley RM. Collecting and managing multisource and multimethod data in studies of pediatric populations. J Pediatr Psychol. 2002; 27(1):5–18. doi:https://doi.org/10.1093/jpepsy/27.1.5.